 |
Previous Article | Next Article 
Volume 17, Number 1,
Issue of January 1, 1997
pp. 125-139
Copyright ©1997 Society for Neuroscience
Developmental Expression of Platelet-Derived Growth
Factor -Receptor in Neurons and Glial Cells of the Mouse CNS
Brahim Nait Oumesmar,
Lionel Vignais, and
Anne Baron-Van Evercooren
Institut National de la Santé et de la Recherche
Médicale U134, Laboratoire de Neurobiologie Cellulaire,
Moleculaire et Clinique and CJF Laboratoire de la Pathologie de la
Myéline, 75651 Paris Cedex 13, France
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT
The synthesis of platelet-derived growth factor- receptor
(PDGF- R) is commonly attributed to oligodendrocyte progenitors during late embryonic and postnatal development. However, we recently demonstrated that mature neurons could also synthesize PDGF- R, emphasizing a larger role for this receptor than previously described. In the present study, to analyze the pattern of PDGF- R expression during postnatal development of the mouse CNS, we used in
situ hybridization and immunohistochemistry on brain and spinal
cord tissue sections. We found that, in addition to immature cells of
the oligodendrocyte lineage, neurons of various CNS regions express
PDGF- R transcripts and protein as early as postnatal day 1 (P1).
Whereas neuronal expression was maintained at all ages, the
oligodendroglial expression strongly decreased after P21. In the adult,
PDGF- R was detected in very few oligodendrocyte progenitors
scattered in the cerebral cortex or in white matter tracts, thus
suggesting the presence of PDGF- R on O-2Aadult
progenitors. In the mature CNS, PDGF- R transcripts and protein were
mainly localized in neurons of numerous structures, such as the
olfactory bulb, cerebral cortex, hippocampus, and brainstem nuclei and
in motor neurons of the ventral horn of the spinal cord. The
differential expression of PDGF- R in oligodendroglia and neurons
argues in favor of several roles of PDGF during development.
Key words:
platelet-derived growth factor;
PDGF -receptor;
oligodendrocyte lineage;
neurons;
CNS development;
in situ
hybridization;
immunohistochemistry
INTRODUCTION
Platelet-derived growth factor (PDGF) was
initially described for its potent mitogenic activity on smooth muscle
cells, fibroblasts (Ross et al., 1974 ; Brewitt and Clark, 1988), and
glial cells (Westermark and Wasteson, 1976 ; Besnard et al., 1987 ). It
also mediates other crucial functions during embryonic development (Mercola et al., 1990 ; Schatteman et al., 1992 ), tissue repair (Shimokado et al., 1985 ), chemotactism (Grotendorst et al., 1989; Hosang et al., 1989 ), extracellular matrix synthesis (Narayanan et al.,
1983; Bauer et al., 1985 ; Chua et al., 1985; Majack et al., 1987 ), and
cytoskeleton rehandling (Mellstrom et al., 1988; Eriksson et al.,
1992 ).
PDGF is encoded by two genes (PDGF-A and PDGF-B) and is active as a
disulphide-linked dimer (Antoniades, 1981 ). Two structurally related
PDGF receptors have been identified, a 170 kDa receptor (PDGF- R)
(Matsui et al., 1989 ) and a 190 kDa receptor (PDGF- R) (Yarden et
al., 1988). These receptors belong to the tyrosine kinase receptor
family. PDGF- R can bind both PDGF-A and PDGF-B chains, whereas receptor binds only the PDGF-B chain. The binding of the ligand dimer
induces dimerization of the receptor, leading to intracellular tyrosine
kinase activity (for review, see Ullrich and Schlessinger, 1990 ).
Several in vitro studies have reported on the importance of
PDGF in the development and differentiation of the oligodendrocytes, the myelin-forming cells of the CNS. Oligodendrocytes arise from a
bipotential precursor, the oligodendrocyte-type-2 astrocyte, named
O-2A, which is able to proliferate and differentiate, under the control
of appropriate growth factors, into either mature oligodendrocytes or
type-2 astrocytes (Lillien et al., 1988 ; Noble et al., 1988 ; Raff et
al., 1988 ; McKinnon et al., 1993 ). In vitro, the O-2A cell
could be maintained in the cell cycle by the coordinated action of bFGF
and PDGF, bFGF upregulating the transcription of the PDGF- R
(McKinnon et al., 1990 ). Moreover, PDGF is the only known
chemoattractant factor for O-2A progenitors (Armstrong et al.,
1990 ).
In vivo, PDGF-A and -B forms are constitutively produced by
neurons within the developing and mature CNS (Sasahara et al., 1991 ;
Yeh et al., 1991 ) and by type-1 astrocytes in the optic nerve
(Richardson et al., 1988 ; Pringle et al., 1989 ). These data suggest
that neurons, in addition to astrocytes, could regulate targeting,
proliferation, and differentiation of oligodendrocyte precursors before
myelination (Yeh et al., 1991 ; Barres et al., 1993). Although
oligodendrocyte progenitors have been detected in the rodent embryonic
CNS by the expression of DM-20 and PDGF- R transcripts, it is unclear
whether these two different cell populations (DM-20+ and
PDGF- R+) are solely restricted to the oligodendroglial
lineage (Pringle et al., 1992 ; Pringle and Richardson, 1993 ; Yu et al.,
1994 ; Timsit et al., 1995 ).
Several studies have failed to detect the expression of PDGF- R on
neurons during embryonic and early postnatal development (Pringle et
al., 1992 ; Yeh et al., 1993 ). Nevertheless, we recently reported that
PDGF- R is mainly localized in mature neurons of the adult mouse CNS
(Vignais et al., 1995 ). Therefore, we hypothesized that PDGF- R is
predominantly expressed in neurons when myelination is achieved. In the
present paper, we analyze the profile of expression of PDGF- R
transcripts and proteins during postnatal development of the mouse CNS.
We report a concomitant expression of PDGF- R by neurons and immature
oligodendroglial cells and a drop in the oligodendroglial expression
when myelination is fully accomplished.
MATERIALS AND METHODS
Animals and tissue processing. Mice of the OF1 strain
were purchased from IFFA-CREDO (Oncins, France) and were 1, 7, 15, 21, 30, and 120 postnatal days old (P). The mice (n = 5 for
each age studied) were perfused intracardially with a solution of 4%
paraformaldehyde in 0.1 M PBS, pH 7.4. Spinal cords and
brains were removed and immersed overnight in the same fixative. They
were then soaked overnight in a solution of 20% sucrose in 0.1 M PBS. Brains and spinal cords were finally embedded in OCT
(Miles, Elkhart, IN), frozen in isopentane ( 60°C), and stored at
40°C until use. Sagittal sections (10 µm thick) were cut on a
Reichert-Jung cryostat (Leica, Germany) and collected on RNase-free
gelatin-coated slides. Free-floating sagittal sections (30 µm thick)
were also cut on a vibratome (Leica), collected in 24-well culture
tissue plates containing 0.1 M sterile PBS, and immediately
processed for in situ hybridization and immunohistochemistry (IHC) procedures.
Western blot analysis. Brains of P1, P7, and P120 mice were
homogenized in Tris-saline buffer, pH 6.8, containing 0.5%
deoxycholate, 0.5% Triton X-100, 2 µg/ml aprotinin, and 1 mM phenylmethyl sulfonyl fluoride and spun at 150,000 × g for 10 min. Solubilized material was boiled for 10 min
in a buffer containing 3% SDS and 5% dithiothreitol, and proteins
(20-50 µg) were separated by SDS-PAGE (7% acrylamide gel). After
electrophoresis, proteins were transferred to nitrocellulose membrane.
The membranes were then Ponceau-stained to verify equal loading and
transfer of proteins. After destaining, the membranes were incubated in
blocking buffer (20 mM Tris, 150 mM NaCl,
0.05% Tween-20, and 5% powdered nonfat milk, pH 7.4) for 2 hr at room temperature. The membranes were then washed three times in 0.1 M PBS (10 min each) and incubated for 2 hr in the blocking
buffer with anti-mouse PDGF- R antibody (UBI, Lake Placid, NY) at the working dilution of 1:500. After incubation with the primary antibody, the blot was washed with PBS and incubated for 2 hr with horseradish peroxidase (HRP)-conjugated swine anti-rabbit IgG antibody (1:500 dilution; Dakopatts, Denmark). Labeled bands were revealed in 0.1 M Tris-HCl, pH 7.6, containing 0.03% DAB (Dakopatts),
0.5% NiCl2, and 0.02% H2O2. The
membrane was washed in water and air-dried. In this Western immunoblot
analysis, cellular protein preparation from mouse 3T3 mouse cells (UBI)
was used as a positive antigen control.
IHC. In this study, the following antibodies were used: a
rabbit polyclonal anti-mouse PDGF- R antibody raised against the 110 C-terminal amino acid residues of the murine PDGF- R (UBI), an
antibody that is specific for the receptor and does not cross-react with the receptor (Cheng and Mattson, 1995 ); a rabbit polyclonal anti-PDGF- R antibody (PDGFR-7, a kind gift from Prof. C. H. Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden) raised against
the cytoplasmic domain of human PDGF- R and specific to the PDGF- R
(Eriksson et al., 1992 ); a monoclonal anti-GFAP (mouse IgG1, Dakopatts)
to stain astrocytes; a rat monoclonal anti-F4/80 (rat IgG2b, Serotec,
Oxford, UK), which specifically recognizes activated microglia and
macrophages in the mouse CNS (Austyn and Gordon, 1981 ); a mouse Rip
monoclonal antibody (mouse IgG1, a kind gift from Dr. B. Friedman),
which labels differentiated oligodendrocytes (Friedman et al., 1989 ;
Jhaveri et al., 1992); an anti-MAP2a+b monoclonal antibody, used to
identify neurons (mouse IgG1, Sigma, St. Louis, MO); and a mouse
monoclonal anti-PSA-NCAM (mouse IgM, a kind gift from Dr. G. Rougon,
Marseille, France) raised specifically against the 2-8-linked
N-acetylneuraminic acid units of the embryonic form of N-CAM
(Rougon et al., 1986 ), which was used as a marker of neural stem cells.
The identification of the cell types expressing PDGF- R was assessed
by double-immunostaining procedures using the polyclonal anti-PDGF- R
with each of the antibodies described above. Working dilutions were as
follows: anti-mouse PDGF- R, 1:200; PDGFR-7 antibody, 1:200; Rip
antibody, 1:2; anti-GFAP, 1:100; anti-F4/80, 1:40; anti-MAP2, 1:100;
anti-PSA-NCAM, 1:100.
For IHC, vibratome sections were rinsed three times in 0.1 M PBS (5 min each) and incubated with 10% normal swine
serum (Life Biotechnologies, Gaithersburg, MD) in 0.1 M PBS
for 30 min to reduce nonspecific staining. Sections were then incubated
overnight at 4°C with constant agitation, in a double-immunolabeling
procedure, with the primary antibodies diluted in PBS containing 10%
normal swine serum. They were then rinsed three times in PBS (10 min each) and incubated for 2 hr with the appropriate secondary antibodies: swine FITC-conjugated anti-rabbit IgG (Dakopatts), goat
TRITC-conjugated anti-mouse IgG1 (Southern Biotechnology, Birmingham,
AL), goat FITC-conjugated anti-mouse IgM (Fab fragments, Tebu, France), or goat TRITC-conjugated anti-rat IgG (Silenus, Hawthorn, Australia). These antibodies were all diluted 1:100 in PBS containing 10% normal
swine serum. Sections were finally rinsed in PBS, mounted on
gelatin-coated slides, air-dried, and mounted with Vectashield mounting
medium (Vector Laboratories, Burlingame, CA). Slides were observed
under fluorescence on a DMRB Leitz microscope. For the PDGF- R IHC
staining, we also used an immunoperoxidase procedure as described above
with additional steps: incubation for 20 min in 0.3%
H2O2 in 0.1 M PBS before saturation
and incubation with the primary and secondary antibody (HRP-conjugated
swine anti-rabbit IgG, 1:100 dilution, Dakopatts). Peroxidase
histochemistry was performed in 0.05 M Tris-HCl, pH 7.3, containing 0.03% DAB (Dakopatts), 0.5% NiCl2, and 0.003%
H2O2 and was stopped in water. Floating sections were mounted as described above, and slides were dehydrated in
ethanol, clarified in xylene, and mounted in Eukitt (Kindler GmbH,
Freiburg, Germany). In each double-immunolabeling experiment, we
systematically performed control single labeling, using each primary
antibody separately. Control sections were made by omitting primary
antibodies and were always free of labeling (data not shown).
In situ hybridization. In situ hybridization (ISH) was
performed as described previously (Vignais et al., 1995 ) using a
digoxigenin-labeled oligonucleotide probe complementary to the murine
PDGF- R (30 mer, 5 -GACAATGACAATCACCAACAGCACCAACAC-3 ). This
antisense DNA single-stranded oligonucleotide probe 5 - and
3 -digoxigenin end-labeled was purchased from R&D Systems (Abingdon,
UK). Free-floating sections were briefly washed in PBS, transferred
into prehybridization solution (50% deionized formamide, 4× SSC, and
1× Denhardt's solution) for 1 hr at 37°C, and washed in 4× SSC for
10 min. Sections were then incubated in the hybridization buffer (50%
deionized formamide, 4× SSC, 1% Denhardt's solution, 5% dextran
sulfate, 100 µg/ml yeast t-RNA, and 250 µg/ml sheared herring
salmon sperm DNA) containing the digoxigenin-labeled probe at the final
concentration of 5 ng/µl for 16 hr at 42°C. Thereafter, they were
washed, respectively, in 2× SSC for 1 hr, 1× SSC for 1 hr, 1× SSC at
37°C for 30 min, 1× SSC for 30 min at room temperature and, finally,
in 0.5× SSC for 30 min. Before immunological detection of hybridized
probes, sections were washed in buffer A (100 mM Tris-HCl,
150 mM NaCl, pH 7.5) and then preincubated in the same
buffer containing 2% normal sheep serum and 0.3% Triton X-100 for 30 min. This was followed by incubation overnight at 4°C with the
anti-digoxigenin alkaline phosphatase (AP)-conjugated antibody (FAB
fragment, Boehringer Mannheim, Mannheim, Germany) diluted at 1:500 in
buffer A containing 0.1% Triton X-100 and 1% normal sheep serum.
After the incubation, sections were rinsed in buffer A (3 times, 10 min
each) and twice (10 min each) in buffer B (100 mM Tris-HCl,
100 mM NaCl, 50 mM MgCl2, pH 9.5).
The AP activity was detected using 45 µl of nitroblue tetrazolium
solution, 35 µl of X-phosphate
(5-bromo-4-chloro-3-indolyl-phosphate), and 0.24 mg/ml Levamisole
(Sigma) in buffer B. The chromogen reaction was monitored for 2-5 hr
and stopped with a solution containing 100 mM Tris-HCl and
0.1 mM EDTA, pH 7.5. Sections were washed extensively,
mounted on gelatin-coated slides, air-dried, and coverslipped in 50%
PBS/50% glycerol. No specific labeling was observed when the antisense
probe was omitted from the hybridization solution. A control procedure,
either preincubation with 20 µg/ml RNase A (Boehringer Mannheim) for
30 min at 37°C or competition with a 40-fold excess of the unlabeled
antisense probe in the hybridization mixture, abolished all specific
mRNA signal.
RESULTS
Immunoblot analysis and specificity of anti-mouse
PDGF- R antibody
Western blot analysis was performed on total protein extracts from
P1, P7, and P120 mouse brain to demonstrate the specificity of the
anti-mouse PDGF- R antibody. In Western immunoblotting, 170 and 140 kDa protein bands immunoreactive with the anti-mouse PDGF- R antibody
were detected in homogenates from P1 (Fig. 1, lane
3), P7 (Fig. 2, lane 2), and
P120 (Fig. 1, lane 1) mouse brain as well as in
cellular protein preparation from mouse 3T3 cells (Fig. 1, lane
4), used as a positive antigen control. These two
immunoreactive bands correspond to the PDGF- R species that had been
identified previously with the PDGF-R7 antibody (Eriksson et al., 1992 ;
Nishiyama et al., 1996 ). The 140 kDa band may represent the precursor
form of the PDGF- R as demonstrated by pulse-chase analysis by
Eriksson et al. (1992) .
Fig. 1.
Western blot characterization of anti-mouse PDGF
-R, antibody in protein extracts from P1, P7, and adult mouse brain.
The anti-mouse PDGF- R recognizes 170 and 140 kDa protein bands,
equivalent to the estimated size of the mature form and the precursor
form, respectively, of the PDGF -R in adult (lane 1),
P7 (lane 2), and P1 (lane 3) mouse brain,
and mouse 3T3 cells (lane 4), used as a positive
antigen control. The relative migration positions of the molecular
weight standards (myosin, 200,000; phosphorylase b, 97,000; bovine
serum albumin, 66,000), run in parallel, are indicated.
[View Larger Version of this Image (77K GIF file)]
Fig. 2.
Expression of PDGF- R in the P1 mouse brain.
A, Immunodetection of PDGF- R protein in the
prefrontal cortex. PDGF- R is localized on neurites and neuronal cell
bodies. B, Immunoreactivity for PDGF- R in the
entorhinal cortex. PDGF- R is widely expressed in the cerebral cortex
(Cx) as well as in presumptive white matter structures,
as illustrated for the corpus callosum (CC) and fibers of the striatum (St) in C. Striatal
neurons are not stained with the polyclonal anti-PDGF- R.
D, Immunostaining of cells of the periventricular zone
of the lateral ventricle. Magnification: A, B, D, 200×;
C, 50×.
[View Larger Version of this Image (156K GIF file)]
Expression of PDGF- R in the newborn mouse brain
The expression of PDGF- R was analyzed by IHC and nonradioactive
ISH during postnatal development of the mouse CNS. In the newborn mouse
brain, the immunohistological expression of PDGF- R was widely
distributed (Fig. 2). At this age, most brain structures showed intense
PDGF- R immunoreactivity. In the cerebral cortex, immunoreactivity
was localized on neurites and in neuronal-like cell soma (Fig.
2A,B) and in well characterized neuronal structures, such as the hippocampus (see Table 1). The presumptive
white matter was also strongly immunoreactive for PDGF- R. The corpus callosum and fibers of the striatum were immunolabeled with the anti-PDGF- R antibody (Fig. 2C). This expression of
PDGF- R was observed only on unmyelinated fibers throughout the first
postnatal week and decreased with myelination. The expression of
PDGF- R was also observed in the periventricular areas, such as the
subventricular zone (SVZ) of the lateral ventricle (Fig.
2D). In these regions, the immunoreactivity was
localized on round cells clustered around the ventricle. In sagittal
sections, this expression spread out to ependymal/subependymal layer of
the olfactory ventricle (not shown). At P1, the intense
immunoreactivity for PDGF- R made the immunological identification of
cell types expressing PDGF- R difficult. However, at P7, neurons of
the cerebral cortex stained with the anti-MAP2 antibody expressed
PDGF- R (Fig. 6E,F). The neuronal expression
of PDGF- R was clearly evidenced, as early as P1, in the cerebellum
(Fig. 3A,B) and the hippocampus (not shown).
Fig. 6.
Immunocharacterization of the cell types
expressing PDGF- R. Double immunostaining with anti-PDGF- R
(A) and Rip (B) on P21 sagittal brain
section. PDGF- R-positive cells (arrowheads in A) are weakly stained with the Rip antibody
(B). Often, there is not strict colocalization between
PDGF- R and Rip expression (arrow), suggesting that
these single-labeled cells could be immature cells of the
oligodendrocyte lineage. P21 sagittal brain section immunolabeled for
PDGF- R (C) and GFAP (D).
Arrowheads in C indicate PDGF- R-positive cells that do not express GFAP in D.
P7 sagittal brain section through the cerebral cortex stained for
PDGF- R (E) and MAP2 (F).
Neurons (arrowheads) stained with the anti-MAP2 antibody
(E) express PDGF- R (F).
Magnification, 224×.
[View Larger Version of this Image (176K GIF file)]
Fig. 3.
Evolution of PDGF- R immunoreactivity in the
developing cerebellum. Immunodetection of PDGF- R in the cerebellum
at P1 (A, B), P7 (C, D), and P15
(E, F). PDGF- R immunoreactivity is detected in
the Purkinje cell layer, the granule cell layer, and the presumptive white matter (A). High-magnification view showing
PDGF- R immunoreactivity on Purkinje and granule cells. Note the lack
of expression in the external germinal layer (B). The
expression of PDGF- R is also widely distributed in the P7 cerebellum
(C). High-magnification view of immunostained Purkinje
and granule cells (D). At this period of development,
the protein is well evidenced in the Purkinje cell soma and dendrites.
At P15, PDGF- R immunoreactivity is considerably decreased in the
granule cell layer and is not detected on white matter fibers
(E, F). The expression is always observed in the soma and dendritic tree of Purkinje cells (arrows in
F) and in oligodendrocyte progenitors
(arrowheads in F). Magnification: A, C, E, 100×; B, D, F, 200×.
EGL, External germinal layer; ML, molecular layer; PL, Purkinje cell layer;
GL, granule cell layer; WM, white
matter.
[View Larger Version of this Image (203K GIF file)]
Developmental expression of PDGF- R in the cerebellum
The developmental expression of PDGF- R is illustrated for the
cerebellum from P1 to P15 (Fig. 3). In the P1 cerebellum, PDGF- R immunoreactivity was noted in the Purkinje and granule cell layer, whereas the external germinal layer that gives rise to the granule cells was not stained at any of the ages studied (Fig.
3A,B). Fibers of the presumptive white matter, which at this
stage are still unmyelinated, were strongly immunolabeled. At P7, the
pattern of PDGF- R immunostaining had a similar profile to P1,
although with a few modifications. The expression of PDGF- R by
Purkinje cells was more obvious at this time of development. PDGF- R
immunoreactivity was localized in the soma and dendritic tree of these
cells, which formed a pluricellular layer. The presumed descending
granule cells from the external germinal layer as well as the internal granule cell layer were also highly immunoreactive for the PDGF- R (Fig. 3C,D). At P15 (Fig. 3E,F), the
expression of PDGF- R decreased compared with P1 and P7. Purkinje
cells remained highly immunoreactive for PDGF- R, whereas the
immunolabeling in the granule cell layer decreased considerably and
became undetectable in the mature cerebellum (see Fig.
9A,B). The staining was seen throughout the cytoplasm and
was also evident in the branches of the dendritic tree of the Purkinje
cells, their axons remaining unlabeled (Fig. 3F). At
P15, labeling of the fiber tracts disappeared and a new
PDGF- R+ cell type was visualized within the cerebellum
white matter (Fig. 3E,F). These positive cells were
probably immature cells of the oligodendrocyte lineage. Their
appearance seems to be correlated with the active myelination that
occurs at this time in the cerebellum (Foran and Peterson, 1992 ). The
developmental evolution of PDGF- R immunoreactivity in the mouse
cerebellum showed a transient expression of the PDGF- R by granule
cells coinciding with their genesis from the external germinal layer
and their migration toward the molecular and Purkinje cell layer
(Altman, 1972 ).
Fig. 9.
Expression of PDGF- R in the adult cerebellum
and brainstem nuclei. In the adult cerebellum, the expression of
PDGF- R is detected only in the Purkinje cell layer
(PL), whereas the molecular (ML) and
granule cell layers (GL) remained unstained with the anti-PDGF- R (A). B, High-magnification
view of the immunoreactivity in the soma and dendritic processes of
Purkinje cells. Note that PDGF- R immunoreactivity is not found in
Purkinje cell axons. C, Immunodetection of PDGF- R in
neurons of the interpositus cerebelli nucleus. D,
High-power view of PDGF- R-positive neurons of the interpositus
cerebelli nucleus. E, PDGF- R immunoreactivity in the
facial nucleus. F, High-magnification view of the
staining of facial nucleus neurons. Magnification: A, C,
110×; B, D, 220×; E, 130×;
F, 260×.
[View Larger Version of this Image (171K GIF file)]
Neurons express PDGF- R transcripts during
postnatal development
To verify whether neurons could synthesize the PDGF- R, the
transcripts of PDGF- R were detected by nonradioactive in
situ hybridization on free-floating brain and spinal cord sections from P1 to adulthood. PDGF- R transcripts were detected in neurons as
early as P1 (not shown). At P15, a strong signal for PDGF- R transcripts was found in most neuronal populations (Fig.
4). For instance, cortical neurons of the prefrontal
cortex exhibited a strong in situ hybridization signal (Fig.
4A). High magnification of this labeling clearly
showed the localization of PDGF- R on neurons, identified by their
large size and their location (Fig. 4B). Neurons of
the hippocampal formation also expressed PDGF- R mRNA (Fig.
4C); likewise, a similar pattern of PDGF- R transcript expression was found at P1 and P7 (not shown). In white matter structures, such as the corpus callosum or the fimbria, the expression of PDGF- R mRNA could be visualized in small glial cells aligned along the fiber tracts (Fig. 4C). These cells belonged to
the oligodendrocyte lineage, as reported previously (Pringle et al., 1992 ; Pringle and Richardson, 1993 ; Yeh et al., 1993 ). In P15 mouse
spinal cord, motoneurons expressed PDGF- R transcripts as did glial
cells (Fig. 4D,E). In adjacent sections, PDGF- R
protein was localized in the same cell types by IHC using the
anti-PDGF- R antibody (Fig. 4F). The expression of
PDGF- R in motoneurons was first observed around P15 and persisted in
the mature CNS. Therefore, these results seem to demonstrate that a
great majority of CNS neurons express PDGF- R during postnatal
development.
Fig. 4.
In situ hybridization and IHC of
PDGF- R on P15 brain and spinal cord tissue sections. Expression of
PDGF- R transcripts in the cerebral cortex (A).
High-magnification view of the hybridization signal showing the
localization of PDGF- R mRNA in the soma of cortical neurons
(arrows in B). Detection of PDGF- R
transcripts in the hippocampus (C) and in motoneurons
(arrowheads) of the spinal cord (D).
Longitudinal spinal cord section, hybridized with the
digoxigenin-labeled antisense probe complementary to murine PDGF- R,
showing the localization of the transcripts in motoneurons
(arrowheads) and oligodendrocyte precursors
(arrows; E). Adjacent section
immunolabeled with the anti-PDGF- R antibody (F). Note that motoneurons and immature cells of
the oligodendrocyte lineage express PDGF- R transcripts and protein.
CA1, CA3, Hippocampal fields;
DG, dentate gyrus. A-D, E, Bright-field
and phase-contrast; F, indirect immunofluorescence.
Magnification: A, C, E, F, 124×; B, D,
248×.
[View Larger Version of this Image (214K GIF file)]
PDGF- R is expressed by oligodendrocyte progenitor cells
From P1 to P7, progenitor cells clustered around periventricular
zones such as the subventricular zone of the lateral ventricle and were
immunolabeled with the polyclonal anti-PDGF- R antibody (Fig.
1D). From P7 to P21, the thickness of this zone
decreased in correlation with the emergence of immature cells of the
oligodendrocyte lineage in other locations, such as the cerebral cortex
(Fig. 5A,C) and the thalamus (Fig.
5E). During the period of active myelination (P15-P21),
cells belonging to the oligodendrocyte lineage were strongly
immunolabeled in white matter structures, like the corpus callosum.
These positive cells with several processes spread out from the corpus
callosum to the cerebral cortex, suggesting their genesis and radial
migration from the SVZ (Fig. 5A,B). In the cerebral cortex,
many immunolabeled immature cells of the oligodendrocyte lineage with
several processes were detected along PDGF- R+ neurites
(Fig. 5C). However, PDGF- R immunoreactivity was always stronger in oligodendroglial cells than in neurons. The concomitant expression of PDGF- R by neurons and glial cells belonging to the
oligodendrocyte lineage was clearly evidenced at this period of
development, as observed in the subiculum (Fig. 5D). At P21, the immunological expression of PDGF- R by immature cells of the oligodendrocyte lineage extended to most of the CNS regions, such as
the thalamus (Fig. 5E) and cerebellar white matter (Fig.
5F). These PDGF- R+ cells displayed
common morphological features of premyelinating oligodendrocytes. By
double IHC, combining the anti-PDGF- R antibody with cell-specific
markers such as Rip, anti-GFAP, anti-F4/80, or anti-MAP2 antibodies,
which recognize differentiated oligodendrocytes, astrocytes, microglia,
and neurons, respectively, immunocolocalization with neither F4/80 (not
shown) MAP2 nor GFAP (Fig. 6C,D) was observed in this PDGF- R+ cell type. In contrast, a colocalization
of Rip and PDGF- R was observed in this cell type (Fig.
6A,B), demonstrating that these cells are
premyelinating oligodendrocytes. Strict colocalization between
PDGF- R and Rip expression was frequently not observed, thus
suggesting that these PDGF- R+ cells could also be more
immature cells of the oligodendrocyte lineage. Mature oligodendrocytes
were not found to express PDGF- R once myelination was complete,
arguing in favor of downregulation of PDGF- R expression in
oligodendrocytes in correlation with their differentiation and
myelinating behavior. In the adult mouse CNS, the oligodendroglial
expression of the PDGF- R was considerably decreased. Very few
oligodendroglial progenitors were immunologically detected in the
cerebral cortex (Fig. 7C) or in the spinal
cord white matter (Fig. 7D). Cells located around the
subventricular zone of the lateral ventricle and the
ependymal/subependymal layer of the olfactory ventricle were labeled
with the anti-PDGF- R antibody (Fig. 7A). These cells,
stained with the anti-Men B antibody raised specifically against the
embryonic form of N-CAM (Fig. 7B), are the migrating neural
stem cells described recently by Lois and Alvarez-Buylla (1994) and
Rousselot et al. (1995) .
Fig. 5.
Expression of PDGF- R by immature
oligodendrocytes in the P21 mouse brain. Spreading of
PDGF- R-positive cells (arrowheads), belonging to
progenitor stages of the oligodendrocyte lineage, from the corpus
callosum (CC) to the cerebral cortex (A).
High-power view showing the morphology of these PDGF- R-positive
cells in the corpus callosum (B). View of the cerebral
cortex, showing the concomitant expression of PDGF- R by neurons
(arrows) and immature cells of the oligodendrocyte
lineage (arrowheads) extending several processes in
contact with PDGF- R-positive neurites (C). Expression
of PDGF- R by neurons (arrow) and oligodendroglial cells (arrowheads) in the subiculum (D).
Oligodendrocyte progenitors, stained with the anti-PDGF- R antibody,
in the thalamus (E) and in cerebellar white matter
(arrowhead in F). Magnification:
A, D, 124×; B, C, E, F,
248× .
[View Larger Version of this Image (162K GIF file)]
Fig. 7.
Immunodetection of PDGF- R in stem cells and
oligodendrocyte progenitors of the adult mouse CNS. Neural stem cells
of the subependymal/ependymal layer of the olfactory bulb are stained for PDGF- R (A). These cells also express PSA-NCAM
(B, adjacent section). In the adult CNS, very few
oligodendrocyte progenitors (arrows) stained with the
anti-PDGF- R antibody were detected in the cerebral cortex
(C) and spinal cord white matter (D).
Magnification, 200×.
[View Larger Version of this Image (134K GIF file)]
Persistent expression of PDGF- R proteins and transcripts in
neurons of the adult mouse CNS
The most striking observation in our study is that PDGF- R
protein and transcripts were mainly localized in mature neurons. The
neuronal distribution of the PDGF- R immunoreactivity is indicated in
Table 1 and is illustrated for several regions of the adult mouse CNS
(see Figs. 8, 9). In the olfactory bulb, PDGF- R
immunoreactivity was localized in neurons of the mitral layer as well
as on neurites of the external plexiform layer (not shown). In
pyramidal neurons of cerebral cortex layer V, the receptor was mainly
present on the axons and weakly present in the cytoplasm (Fig.
8A). In the hippocampus, pyramidal neurons of the
CA1-CA3 regions and granule neurons of the dentate gyrus were strongly
immunolabeled (Fig. 8B). In the subiculum, PDGF- R
immunoreactivity was observed principally on the axons (Fig.
8C), whereas in the globus pallidus (Fig.
8D) and substantia nigra (Fig.
8E,F), PDGF- R protein was mainly localized in the neuronal cell bodies. In the adult cerebellum, Purkinje cells
(Fig. 9A) as well as deep cerebellar nuclei
neurons were strongly immunolabeled with anti-PDGF- R (Fig.
9C,D). In the Purkinje cell layer, the immunoreactivity was
always localized in the soma and the dendritic tree, whereas their
axons remained constantly unlabeled, as in the molecular and granule
cell layer (Fig. 9B). Most brainstem nuclei, like the facial
nucleus (Fig. 9E), highly expressed the PDGF- R. In this
nucleus, the immunolabeling was observed in the neuronal cytoplasm, on
dendrites, and on the initial segment of axons (Fig.
9F). In the adult mouse spinal cord, the expression
of PDGF- R was mainly detected in neurons of the dorsal horn and
motoneurons of the ventral horn (see Table 1). In control experiments,
the same pattern of immunoreactivity for PDGF- R was also observed on
adult rat brain floating sections (data not shown), thus confirming
that the neuronal expression of PDGF- R was not related to species
differences between mice and rats. Moreover, immunolabeling performed
on adult mouse brain with the PDGFR-7 antibody, raised against the
cytoplasmic domain of human PDGF- R (Eriksson et al., 1992 ), clearly
confirmed the localization of the PDGF- R on neurons (data not
shown).
Fig. 8.
Localization of PDGF- R immunoreactivity in the
adult mouse brain. Immunodetection of the PDGF- R protein in neurons
(arrows) of the cerebral cortex (A),
hippocampus (B), subiculum (C), globus pallidus (D), and substantia nigra (E).
High-power view of PDGF- R-positive neurons of the substantia nigra
pars reticulata showing the localization of the protein in the neuronal
cell bodies, dendrites, and initial segment of the axons
(F). A, B, Immunoperoxidase;
C, D-F, immunofluorescence. DG, Dentate
gyrus; CA3, hippocampal field. Magnification: A,
B, C, E, 124×; D, F, 248×.
[View Larger Version of this Image (185K GIF file)]
In view of the wide distribution of PDGF- R protein observed in
mature neurons, we proceeded to look for a constitutive expression of
the PDGF- R gene in this cell population. PDGF- R gene expression in the adult brain was assayed by in situ hybridization
using a PDGF- R antisense oligonucleotide probe end-labeled with
digoxigenin. Figure 10 illustrates the presence of
PDGF- R mRNA in adult mouse brain sections. PDGF- R transcripts
were detected in neurons of several regions, including the hippocampus
(Fig. 10A), subiculum and entorhinal cortex (Fig.
10B), substantia nigra (Fig. 10C),
Purkinje cell layer of the cerebellum (Fig. 10D), and
the vestibular nucleus (Fig. 10E). We also observed
PDGF- R mRNA in neurons of the olfactory bulb, cerebral cortex, and
the thalamus, whereas a specific in situ hybridization
signal was not detected in any striatal neurons (not shown). PDGF- R
transcripts were not detected in white matter structures, as in the
corpus callosum (Fig. 10A,B). Control brain tissue
sections, hybridized with the PDGF- R sense oligonucleotide probe
end-labeled with digoxigenin, were always free of mRNA signal (Fig.
10F). The same result was obtained by digestion of
the cellular signal with RNase A before the hybridization step or by
competition with a 40-fold excess unlabeled probe in the hybridization
mixture. The presence of PDGF- R protein and transcripts in the same
CNS structures argues in favor of a constitutive expression of this receptor by neurons.
Fig. 10.
Detection of PDGF- R transcripts in the adult
mouse CNS by nonradioactive in situ hybridization.
PDGF- R mRNA are widely expressed in neuronal populations, as
illustrated for the hippocampus (A), subiculum and
entorhinal cortex (B), substantia nigra pars compacta (C), Purkinje cell layer of the cerebellum
(D), and neurons of the vestibular nucleus
(E). Hybridization signal is not observed in white
matter structures, such as the corpus callosum (A, B). F, Control in situ hybridization with the
PDGF- R digoxigenin-labeled oligonucleotide sense probe performed on
sagittal brain tissue section through the cerebellum.
A-F, Bright-field and phase-contrast. DG, Dentate gyrus; CA1,
CA3, hippocampal fields; CC, corpus
callosum; ML, molecular layer; PL,
Purkinje cell layer; GL, granule cell layer.
Magnification: A, 110×; B, D, F, 220×;
C, E, 300×.
[View Larger Version of this Image (169K GIF file)]
DISCUSSION
The present findings illustrate for the first time the
presence of the PDGF- R in neurons during postnatal development of the mouse CNS. The expression of this receptor is detected in neurons
as early as P1 and persists throughout adulthood. Our data also
demonstrate that the prominent expression of PDGF- R in
oligodendrocyte progenitor cells during myelination is downregulated in
the adult CNS, as demonstrated previously (Reddy and Pleasure, 1992 ;
Yeh et al., 1993 ; Ellison and de Vellis, 1994 ). Although the expression
of PDGF- R is commonly attributed to the O-2A progenitors, the
unexpected neuronal expression reported in this study leads us to
speculate on possible neurotrophic effects of PDGF in the CNS.
Concomitant expression of the PDGF- R by neurons and immature
cells of the oligodendrocyte lineage during postnatal development
Our results show, as do several other studies, the expression of
PDGF- R by immature cells of the oligodendrocyte lineage in the
developing CNS (Pringle et al., 1992 , Yeh et al., 1993 ; Ellison and de
Vellis, 1994 ). The oligodendroglial expression is mainly observed
around subventricular germinal zones and spreads out to most brain
regions during myelination. Indeed, the pattern of PDGF- R expression
is well correlated with the development of the O-2A cells in the
anterior forebrain, as observed by IHC for GD3 (LeVine and Goldman,
1988a ,b) or by in vivo retroviral labeling of the SVZ
progenitors (Levison and Goldman, 1993 ; Luskin and McDermott, 1994 ;
Zerlin et al., 1995 ). In vivo, PDGF-A and -B chains are
widely expressed by neurons of the embryonic and adult CNS (Sasahara et
al., 1991 ; Yeh et al., 1991 ) and type-1 astrocytes (Richardson et al.,
1988 ; Yeh et al., 1991 ), suggesting that neurons, in addition to
astrocytes, could direct targeting, proliferation, and differentiation
of the oligodendroglial progenitors before myelination. Neuronal
control of oligodendrocyte development has been suggested recently by
several studies (Hardy and Reynolds, 1993 ; Barres and Raff, 1994 ;
Burne et al., 1996 ).
The present paper also demonstrates the localization of PDGF- R in
most neurons during early postnatal development, arguing for a more
extended role of this receptor than has been described previously.
PDGF- R is present on most neurons as early as P1 and persists in the
adult CNS. During the first postnatal week of development, PDGF- R
immunoreactivity is mainly found on unmyelinated neurites, suggesting
that this expression could be involved in neurite outgrowth (Fanger et
al., 1995 ). This idea is supported by the presence of PDGF-A chain in
the growth cones of neurons in mid-embryonic brain development
(Hutchins and Jefferson, 1992 ). The involvement of PDGF- R during
development was suggested previously by analysis of the Patch mutation,
a deletion of the PDGF- R. Patch mouse embryos display obvious growth
retardation and deficiencies in mesodermal structures, and late
embryonic defects were associated with both mesodermal and neural crest
derivatives (Morrison-Graham et al., 1992 ; Orr-Urtreger et al., 1992 ;
Schatteman et al., 1992 ). Our results, demonstrating an expression of
PDGF- R by neurons in the developing and mature CNS, also argue for a
crucial role of this receptor in the normal development of the CNS. Its
expression by neurons could be necessary for their differentiation
and/or maturation. For instance, in the developing cerebellum, granule cells expressed the PDGF- R during their maturation and migration toward the molecular and Purkinje cell layers, whereas Purkinje cells
constitutively expressed this tyrosine kinase receptor.
Earlier data reporting a restricted expression of PDGF- R on
oligodendroglia failed to detect its expression on neurons (Pringle et
al., 1992 ; Yeh et al., 1993 ). However, in these studies the expression
of PDGF- R was investigated by in situ hybridization, and
the cell types expressing PDGF- R were identified solely on the basis
of the shape and size of their nucleus. However, Pringle and Richardson
(1993) showed, between E12.5 and E15, a transient expression of
PDGF- R transcripts by presumptive neuronal precursors near the
dorsal alar ventricular zone of the rat spinal cord. Moreover, other
studies have shown the localization of PDGF- R in neurons of the rat
dorsal root ganglion at all stages of postnatal development (Eccleston
et al., 1993 ) and in cultured rodent embryonic hippocampal and cortical
neurons (Cheng and Mattson, 1995 ; Hutchins, 1995 ). Immunohistological
and in situ hybridization analyses of the developmental
expression of PDGF- R reported in this study clearly demonstrate the
expression of PDGF- R by neurons. This result, also obtained with the
PDGFR-7 antibody raised against the cytoplasmic domain of human
PDGF- R (Eriksson et al., 1992 ), firmly establishes the specificity
of this neuronal expression in rat and mouse CNS and excludes both
antibodies and species-related specificity. The differences in results
between previous studies and the present study could be related to the
highly sensitive IHC procedure involving free-floating sections.
Indeed, PDGF- R immunolabeling on neurons was very weak and was not
observed in brain structures, such as the substantia nigra, the
hippocampus, and the thalamus, when frozen brain tissue sections were
used in this study. Neuronal expression of PDGF- R is low in
comparison with oligodendroglial expression and could have been missed
on frozen tissue sections.
Differential regulation of PDGF- R expression in neurons and
oligodendrocyte progenitors
Our data emphasize a differential regulated expression of
PDGF- R in neurons and oligodendrocyte progenitors. In the adult CNS,
the synthesis of PDGF- R persists in numerous neuronal populations, whereas in oligodendrocytes, this expression was downregulated in
correlation with their differentiation. In the mature CNS, the
expression of PDGF- R was detected in very few oligodendrocyte progenitors scattered throughout white matter structures and the cerebral cortex. These rare cells, with a morphology analogous to that
observed during development, could be the O-2Aadult
progenitors isolated from adult tissue (Wolswijk et al., 1991 ). These
cells have also been immunologically characterized by coexpression of
PDGF- R and NG2 proteoglycan (Nishiyama et al., 1996 ). In
vitro, PDGF is mitogenic for O-2Aadult progenitor
cells, and cooperation between PDGF and b-FGF converts these slowly
dividing progenitors to rapidly dividing cells with characteristics of
O-2Aperinatal progenitors (Wolswijk and Noble, 1992 ).
In vivo, it is plausible that these cells may be responsible
for the generation of new oligodendrocytes after myelin damage (for
review, see Wood and Mora, 1993 ). However, the involvement of these
progenitors in remyelination and their response to demyelination remain
to be analyzed. In the adult CNS, PDGF- R is also detected in neural stem cells of subventricular zones, such as the SVZ of the lateral ventricle and the subependymal/ependymal layer of the olfactory ventricle. These cells would mainly represent migrating neural precursors, which generate neurons of the olfactory bulb (Lois and
Alvarez-Buylla, 1993 , 1994 ; Luskin, 1993 ; Rousselot et al., 1995 ).
PDGF, in addition to other proposed molecules such ECM molecules or the
embryonic form of N-CAM (Gates et al., 1995 ), could regulate the
migration and differentiation of neural stem cells of the adult CNS.
PDGF- R activation could mediate instructive, survival, and
neurotrophic effects in the CNS
Several studies have mentioned neurotrophic, instructive, and
neuroprotective effects of PDGF on cultured immature neurons, mediated
through the activation of the two forms of PDGF receptors (Nikkhah et
al., 1993 ; Smits et al., 1993 ; Cheng and Mattson et al., 1995; Fanger
et al., 1995 ). For instance, PDGF-BB exerts trophic activity on
cultured GABAergic interneurons by increasing the expression of
glutamic acid decarboxylase (GAD) and the survival of these cells
(Smits et al., 1993 ). PDGF promotes survival of rat and human
mesencephalic dopaminergic neurons in culture (Nikkhah et al., 1993 )
and, in vitro, induces neurite outgrowth of the PC12
neuronal cell line (Fanger et al., 1995 ). The fact that neurons express
PDGF- R during development and in the adult rodent CNS is in
agreement with the trophic effects reported for PDGF. These neurotrophic effects may be mediated via the neuronal expression of
PDGF- R. Moreover, PDGF treatment of cultured fibroblast leads to the
activation of the voltage-gated calcium channel and to subsequent
calcium influx (Estacion and Moran, 1993). In neurons, similar
mechanisms could regulate neuritic outgrowth and/or neurotransmitter release. More recently, Cheng and Mattson (1995) also reported that
PDGF protect embryonic hippocampal neurons against energy deprivation
and oxidative injury in vitro, by increasing the activity of
antioxidative enzymes like catalase and glutathione peroxidase. Furthermore, PDGF induces phosphorylation of the mitochondrial F1F0 ATPase subunit in mouse cortical
neurons in vitro (Zhang et al., 1995 ). The expression of
both PDGF- R and PDGF- R by neurons and the fact that both PDGF-AA
and PDGF-BB were effective in protecting these cells strongly suggest
that either receptors or receptors can trigger neuroprotective
mechanisms. Thus, the expression of this receptor in mature neurons
could have a physiological role in the normal functioning of neurons
in vivo.
These findings definitively demonstrate that the PDGF- R have a more
extended distribution than reported previously. This observation
suggests that, during early postnatal development, PDGF could play a
role not only in the control of oligodendroglial population but also in
the maturation of neurons and could have a survival or neurotrophic
effect on neurons. The physiological functions of the neuronal
synthesis of PDGF- R remain, however, to be determined.
FOOTNOTES
Received July 29, 1996; revised Oct. 9, 1996; accepted Oct. 21, 1996.
This study was supported by the Myelin Project, the Association pour la
Recherche sur la Sclérose en Plaques, and Institut National de la
Santé et de la Recherche Médicale. B.N.O. is a fellow of
the Société des Amis des Sciences. We are grateful to Dr.
N. Baumann for helpful discussions and C. Bachelin for her technical
assistance. We thank Prof. C. H. Heldin for the kind gift of the
PDGFR-7 antibody and M. C. Nadaud and Dr. H. Villarroya for advice on
Western blots.
Correspondence should be addressed to Dr. Anne Baron-Van Evercooren,
INSERM U134, Laboratoire de Neurobiologie Cellulaire, Moleculaire et Clinique, 47 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France.
REFERENCES
-
Altman J
(1972)
Postnatal development of the cerebellar cortex in the rat. III. Maturation of the components of the granular layer.
J Comp Neurol
145:465-514 .
[ISI][Medline]
-
Antoniades HN
(1981)
Human platelet-derived growth factor: purification of PDGF-I and PDGF-II and separation of their reduced subunits.
Proc Natl Acad Sci USA
78:7314-7317 .
[Abstract/Free Full Text]
-
Armstrong RC,
Harvath L,
Dubois-Dalcq ME
(1990)
Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules.
J Neurosci Res
27:400-407 .
[ISI][Medline]
-
Austyn JM,
Gordon S
(1981)
F4/80: a monoclonal antibody directed specifically against the mouse macrophage.
Eur J Immunol
11:805-815 .
[ISI][Medline]
-
Barres BA,
Raff MC
(1993)
Proliferation of oligodendrocyte precursor cells depends on electrical activity of axons.
Nature
361:258-260 .
[Medline]
-
Barres BA,
Raff MC
(1994)
Control of oligodendrocyte number in the developing rat optic nerve.
Neuron
12:935-942 .
[ISI][Medline]
-
Bauer EA,
Cooper TW,
Huang JS,
Altman J,
Deuel TF
(1985)
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.
Proc Natl Acad Sci USA
82:4132-4136 .
[Abstract/Free Full Text]
-
Besnard F,
Perraud F,
Sensenbrenner M,
Labourdette G
(1987)
Platelet-derived growth factor is a potent mitogen for glial cell but not neuronal rat brain cells in vitro.
Neurosci Lett
73:287-292 .
[ISI][Medline]
-
Brevitt B,
Clark JJ
(1988)
Growth and transparency in the lens, an epithelial tissue, stimulated by pulses of PDGF.
Science
242:777-779.
[Abstract/Free Full Text]
-
Burne J,
Staple JK,
Raff MC
(1996)
Glial cells are increased proportionally in transgenic optic nerves with increased numbers of axons.
J Neurosci
16:2064-2073 .
[Abstract/Free Full Text]
-
Cheng B,
Mattson M
(1995)
PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways.
J Neurosci
15:7095-7104 .
[Abstract]
-
Chua CC,
Gieman DE,
Keller DH,
Ladda RL
(1995)
Induction of collagenase secretion in human fibroblasts culture by growth promoting factors.
J Biol Chem
260:5213-5216.
[Abstract/Free Full Text]
-
Eccleston PA,
Funa K,
Heldin CH
(1993)
Expression of platelet-derived growth factor (PDGF) and PDGF
- and -receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia.
Dev Biol
155:459-470 .
[ISI][Medline]
-
Ellison JA,
de Vellis J
(1994)
Platelet-derived growth factor receptor is expressed by cells in the early oligodendrocyte lineage.
J Neurosci Res
37:116-128 .
[ISI][Medline]
-
Eriksson A,
Siegbahn A,
Westermark B,
Heldin CH,
Claesson-Welsh L
(1992)
PDGF
- and -receptors active unique and common signal transduction pathways.
EMBO J
11:543-550 .
[ISI][Medline]
-
Estacion M,
Mordan LJ
(1993)
Expression of voltage-gated calcium channels correlates with PDGF-stimulated calcium influx and depends upon cell density in C3H 10T1/2 mouse fibroblasts.
Cell Calcium
14:161-171 .
[ISI][Medline]
-
Fanger GR,
Jones JR,
Maue RA
(1995)
Differential regulation of neuronal sodium channel expression by endogenous and exogenous tyrosine receptors expressed in rat pheochromocytoma cells.
J Neurosci
15:201-213.
-
Foran DR,
Peterson AC
(1992)
Myelin acquisition in the central nervous system revealed by an MBP-Lac Z transgene.
J Neurosci
12:4890-4897 .
[Abstract]
-
Friedman B,
Hockfield S,
Black JA,
Woodruff KA,
Waxman SG
(1989)
In situ demonstration of mature oligodendrocytes and their processes: An immunohistochemical study with a new monoclonal antibody, Rip.
Glia
2:380-390 .
[ISI][Medline]
-
Gates MA,
Thomas LB,
Howard EM,
Laywell ED,
Sajin B,
Faissner A,
Götz B,
Silver J,
Steindler DA
(1995)
Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres.
J Comp Neurol
361:249-266 .
[ISI][Medline]
-
Grotendorst GR,
Chang T,
Seppä HEJ,
Kleinman HK,
Martin GR
(1982)
Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells.
J Cell Physiol
113:261-266 .
[ISI][Medline]
-
Hardy R,
Reynolds R
(1993)
Rat cerebral cortical neurons in primary culture release a mitogen specific for early (GD3+/O4
) oligodendroglial progenitors.
J Neurosci Res
34:589-600 .
[ISI][Medline]
-
Heldin CH,
Westermark B
(1990)
Platelet-derived growth factor: mechanism of action and possible in vivo function.
Cell Regul
1:555-566 .
[ISI][Medline]
-
Hosang M,
Rouge M,
Wipf B,
Eggiman B,
Kaufmann F,
Hunziker W
(1989)
Both homodimeric isoforms of PDGF (AA and BB) have mitogenic and chemotactic activity and stimulate phosphoinositol turnover.
J Cell Physiol
140:558-564 .
[ISI][Medline]
-
Hutchins JB
(1995)
Platelet-derived growth factor of mouse central nervous system cells in vitro.
J Comp Neurol
360:59-80 .
[ISI][Medline]
-
Hutchins JB,
Jefferson VE
(1992)
Developmental distribution of platelet-derived growth factor in the mouse central nervous system.
Dev Brain Res
67:121-135 .
[Medline]
-
|